Bilcare Intrinsic Value
Bilcare (BI) median intrinsic value is ₹155.50 from 4 valuation models (range ₹124–₹156), vs current price ₹62.20 — +150.0% upside (Trading Below Calculated Value), margin of safety 60.0%. Browse BI cash flow statement for revenue, profit, balance sheet and cash flow data.
BI Valuation Methods Summary — DCF, Graham Number & P/E
Bilcare intrinsic value across 4 models vs current price ₹62.20 — upside/downside and value range per method. For current market price and key ratios, visit Bilcare share price screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹155.50 | ₹139.95 - ₹171.05 | +150.0% | Book Value/Share: ₹245.83, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹124.40 | ₹111.96 - ₹136.84 | +100.0% | Revenue/Share: ₹305.00, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹124.40 | ₹111.96 - ₹136.84 | +100.0% | EBITDA: ₹32.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹155.50 | ₹124.40 - ₹186.60 | +150.0% | CF Growth: 5.0%, Discount: 15% |
BI Intrinsic Value vs Market Price — All Valuation Models
Bilcare fair value range ₹124–₹156 vs current market price ₹62.20 across 4 valuation models. Also explore BI stock price history to track price trends across different timeframes.
BI Intrinsic Value Analysis — Undervalued or Overvalued?
Bilcare median intrinsic value ₹155.50, current price ₹62.20 — Trading Below Calculated Value by 150.0%, margin of safety 60.0%.
What is the intrinsic value of BI?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Bilcare (BI) is ₹155.50 (median value). With the current market price of ₹62.20, this represents a +150.0% variance from our estimated fair value.
The valuation range spans from ₹124.40 to ₹155.50, indicating ₹124.40 - ₹155.50.
Is BI undervalued or overvalued?
Based on our multi-method analysis, Bilcare (BI) appears to be trading below calculated value by approximately 150.0%.
BI Financial Health — Key Ratios vs Industry Benchmarks
Bilcare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.70 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | -15.6% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 2.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.52x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
BI Cash Flow Quality — Operating & Free Cash Flow
Bilcare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2024 | ₹63 Cr | ₹10 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹-7 Cr | ₹-7 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹41 Cr | ₹39 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹72 Cr | ₹72 Cr | Positive Free Cash Flow | 8/10 |
| March 2020 | ₹256 Cr | ₹256 Cr | Positive Free Cash Flow | 8/10 |